Top

Tag: drug prices


Regulatory

Payers, hospitals pleased as Biden signs sweeping health bill into law

August 17, 2022

Via: Healthcare Dive

On Tuesday, President Joe Biden signed a $740 billion package into law enacting some of the biggest changes to U.S. healthcare since the passage of the Affordable Care Act over a decade ago. The Inflation Reduction Act allows Medicare to […]


News

Price Transparency: Challenges and Solutions for Hospitals

January 27, 2020

Via: HITECH Answers

The call for healthcare price transparency is growing louder, with seemingly obvious benefits. Patients, knowing what they’ll owe, can make informed decisions about their care and how they’ll pay for it. Providers can build trusting relationships and increase the likelihood […]


Regulatory

The Epic Folly Of Trump’s Drug Importation Crusade

January 6, 2020

Via: Forbes

Late last month, the Trump administration released a plan that would green-light the importation of certain drugs from Canada and potentially other foreign countries. The administration’s proposal comes on the heels of legislative pushes by Republican Governor Ron DeSantis of […]


Regulatory

California’s new transparency law reveals steep rise in wholesale drug prices

October 14, 2019

Via: The Medical News

Drugmakers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield. Pharmaceutical companies raised the “wholesale acquisition cost” of […]


News

On Prescription Drug Prices, Will Trump Turn Words Into Action?

July 15, 2019

Via: Forbes

Last week, President Trump declared his administration would soon issue an executive order mandating a so-called “favored nations” policy in which U.S. government (presumably, Medicare and Medicaid) payments for drugs would be capped at the lowest price paid by a […]


News

Drug Prices And Innovation

June 20, 2019

Via: Forbes

The crisis in drug pricing has reached global proportions. According to a recent article in The Economist, “THESE DAYS it is hard to find a government that is not struggling with the high price of medicines. …[T]he unaffordability of medicines…[is […]


News

US companies are expected to spend 6% more on health care next year as drug prices rise

June 20, 2019

Via: CNBC

The presidential hopefuls aren’t the only ones eyeing health care issues for 2020. Large employers are putting together benefit plans for next year, and they are expecting the rise in employee health costs to hit a four-year high, in part, […]


Regulatory

Trump administration wants to shame Big Pharma into lowering drug prices

May 9, 2019

Via: CNBC

The Trump administration wants to shame pharmaceutical companies into lowering prescription drug prices, Health and Human Services Secretary Alex Azar told CNBC in an interview Thursday. Pharmaceutical companies will be required to disclose the list price of their prescription medicines […]


Regulatory

The money and politics of prescription drugs: What you need to know

May 8, 2019

Via: The Medical News

If there’s one area of health care where Republicans and Democrats might strike a deal, it’s prescription drugs. President Donald Trump has floated a plan to cut drug prices. Democratic and Republican ideas abound in Congress, where lawmakers have put […]


News

Outcomes-based Pricing Not A Panacea For High Priced Drugs

March 27, 2019

Via: Forbes

In the battle over the pricing of new drugs, manufacturers and payers have sought to come up with novel approaches to pricing that can be tolerated by both parties. One such approach has been to provide a type of money-back […]


Innovation, News, Patient Experience

For Some Patients Financial Toxicity Is Real And Getting Worse

November 26, 2018

Via: Forbes

The Trump Administration has not been shy about being critical of drug prices, transparency, and other issues it sees as plaguing the prescription drug market. One can say that this Administration has been more proactive in this area than any […]


Regulatory

Drugmakers will soon talk about price in ads — but not as explicitly as Trump administration wants

October 15, 2018

Via: CNBC

Major drugmakers will soon include price information in television advertisements, conceding to the Trump administration but not as far as the administration may have hoped. Starting April 15, 2019, members of the Pharmaceutical Research and Manufacturers of America trade group […]


Regulatory

FDA To Consider Drug Importation In Battle Against High Drug Prices

July 19, 2018

Via: Forbes

Two years ago on this Forbes channel, Scott Gottlieb suggested that Donald Trump’s proposal to import inexpensive prescription drugs from overseas would “offer consumers little relief” from rising drug prices. But that was before Trump became President, named Gottlieb commissioner […]


News

The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system

June 27, 2018

Via: CNBC

Americans continue to suffer the highest prescription drug costs of anyone in the world. One in four are unable to fill prescriptions due to high prices, according to a recent poll. And even though drug prices tripled over the last […]


News, Regulatory

Vermont legislators pass a drug importation law. So what?

May 18, 2018

Via: The Medical News

This week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation of prescription drugs wholesale from Canada. It represents the state’s effort to tackle head-on the issue of constantly climbing drug prices. Other states, including Louisiana and Utah, […]


News

FDA Commissioner Gottlieb: US could see lower drug prices if Europe pays more of its fair share

May 15, 2018

Via: CNBC

U.S. allies’ drug pricing strategies are not sustainable for long-term success, and that’s adversely leading to higher prescription costs at home and abroad, FDA Commissioner Dr. Scott Gottlieb told CNBC on Tuesday. Europeans “do underpay relative to us for branded […]


News

Drug prices continue to climb despite barrage of criticism

March 21, 2018

Via: CNBC

Drug prices are still climbing despite calls to lower them, Axios reports. President Donald Trump has repeatedly chastised the pharmaceutical industry, even accusing them of “getting away with murder.” But since he took office, drugmakers have hiked list prices on […]


Regulatory

Trump hasn’t attacked drug prices like he promised during his first year in office

January 19, 2018

Via: CNBC

Donald Trump raged against the pharmaceutical industry as a candidate. He accused drug companies of “getting away with murder” as president-elect. But he hasn’t done too much to tackle prices as president — yet. Trump has occasionally criticized high drug […]


Regulatory

Congress takes aim at prescription drug costs in hearing but gets sidetracked by ACA repeal bill

June 15, 2017

Via: FierceHealthcare

A bipartisan Senate health committee held the first of three hearings on the rising costs of prescription drugs but didn’t get very far. In many ways it became a gripe session for Democrats over their Republican counterparts’ closed-door session and […]


News

Biotech stocks have worst day in 7 weeks after Trump tweets drug prices will come ‘way down’

March 8, 2017

Via: CNBC

President Donald Trump’s claims that he will bring drug prices “way down” sent health-care stocks tumbling Tuesday morning. On Tuesday, pharmaceutical stocks were the biggest laggards in the S&P 500 for much of the morning, with the health-care sector closing […]